Dr. Meagan Jacoby, M.D., Ph.D.
Claim this profileWashington University School of Medicine
Studies Myelodysplastic Syndrome
Studies Acute Myeloid Leukemia
21 reported clinical trials
34 drugs studied
About Meagan Jacoby, M.D., Ph.D.
Education:
- MD from Washington University School of Medicine.
- PhD in Molecular Genetics and Genomics from Washington University School of Medicine.
Experience:
- Specializes in leukemia at the Siteman Cancer Center.
- Contributes to research, diagnosis, and treatment in her field.
Area of expertise
1Myelodysplastic Syndrome
2Acute Myeloid Leukemia
FLT3 negative
CEBPA positive
Stage II
Affiliated Hospitals
Clinical Trials Meagan Jacoby, M.D., Ph.D. is currently running
CIML NK Cell Therapy
for Acute Myeloid Leukemia
This is a standard phase 2 study powered to demonstrate improvement in the 100 day leukemia free survival to 30% from \<10% expected with the use of reduced intensity haplo-HCT in this extremely high-risk patient cohort (based on the institutional experience using non-myeloablative / reduced intensity conditioning in a similar patient cohort). A formal safety evaluation will be done after every 6th patient enrolled and the trial will be stopped if noted to have unusually higher engraftment failure (acute GVHD rates (\>60% any grades or \>30% grade III/IV or ≥ 50% severe cGVHD) or engraftment failure rates (≥15%).
Recruiting1 award Phase 2
ChromoSeq
for Myelodysplastic Syndrome
This is a single institution, prospective study of the whole genome sequencing assay, ChromoSeq. Using prospectively collected patient data, coupled with physician surveys, the investigators seek to determine the feasibility of implementing ChromoSeq in addition to standard genomic testing, for patients with the diagnosis of myelodysplastic syndrome (MDS).
Recruiting1 award N/A8 criteria
More about Meagan Jacoby, M.D., Ph.D.
Clinical Trial Related1 year of experience running clinical trials · Led 21 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Meagan Jacoby, M.D., Ph.D. has experience with
- ChromoSeq
- Cytokine Induced Memory-like NK Cell Adoptive Therapy
- Fludarabine
- DEC-C
- MyeloSeq-HD
- Pacritinib
Breakdown of trials Meagan Jacoby, M.D., Ph.D. has run
Myelodysplastic Syndrome
Acute Myeloid Leukemia
Arterial Tortuosity Syndrome
Childhood Cancer
- Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AML
- Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS
- Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Graft-versus-Host Disease
- Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease
- ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients
- Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Meagan Jacoby, M.D., Ph.D. specialize in?
Meagan Jacoby, M.D., Ph.D. focuses on Myelodysplastic Syndrome and Acute Myeloid Leukemia. In particular, much of their work with Myelodysplastic Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Meagan Jacoby, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Meagan Jacoby, M.D., Ph.D. is currently recruiting for 8 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Meagan Jacoby, M.D., Ph.D. has studied deeply?
Yes, Meagan Jacoby, M.D., Ph.D. has studied treatments such as ChromoSeq, Cytokine Induced Memory-like NK Cell Adoptive Therapy, Fludarabine.
What is the best way to schedule an appointment with Meagan Jacoby, M.D., Ph.D.?
Apply for one of the trials that Meagan Jacoby, M.D., Ph.D. is conducting.
What is the office address of Meagan Jacoby, M.D., Ph.D.?
The office of Meagan Jacoby, M.D., Ph.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.